Literature DB >> 7862939

Plasma nicotine, plasma beta-endorphin and mood states during periods of chronic smoking, abstinence and nicotine replacement.

M E Wewers1, G A Tejwani, J Anderson.   

Abstract

Nicotine is known to release neuroendocrine substances which may subsequently reinforce smoking behavior by improving mood states. The purpose of this study was to examine changes in plasma beta-endorphin and mood states during periods of chronic smoking, abstinence from smoking, and abstinence while chewing nicotine gum. A modified A-B-A-C design was used. Normal male volunteers were randomly assigned to an experimental or control group. Over a 12-day protocol, experimental subjects smoked ad libitum for 2 days, were abstinent for 4 days, resumed smoking for 2 days, and then chewed nicotine gum for the final 4 days. Control subjects smoked ad libitum throughout the entire protocol. Results indicated that changes in plasma beta-endorphin levels were not related to changes in the four smoking conditions. Plasma nicotine and mood states were related, such that dysphoric moods increased during abstinence from smoking in comparison to the control group. To investigate further the relationships between nicotine, beta-endorphin and reinforcement for smoking, it may be necessary to characterize endogenous opioid peptide release in the central nervous system during smoking.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7862939     DOI: 10.1007/bf02244878

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  24 in total

1.  The tobacco withdrawal syndrome.

Authors:  S M Shiffman
Journal:  NIDA Res Monogr       Date:  1979-01

2.  Psychological and pharmacological influences in cigarette smoking withdrawal: effects of nicotine gum and expectancy on smoking withdrawal symptoms and relapse.

Authors:  Andrew M Gottlieb; Joel D Killen; G Alan Marlatt; C Barr Taylor
Journal:  J Consult Clin Psychol       Date:  1987-08

3.  Cigarette smoking during anxiety-provoking and monotonous tasks.

Authors:  J E Rose; S Ananda; M E Jarvik
Journal:  Addict Behav       Date:  1983       Impact factor: 3.913

4.  Neuroendocrine reactivity to nicotine in smokers.

Authors:  O F Pomerleau; J B Fertig; L E Seyler; J Jaffe
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

5.  Nicotine-induced antinociception in rats and mice: correlation with nicotine brain levels.

Authors:  H L Tripathi; B R Martin; M D Aceto
Journal:  J Pharmacol Exp Ther       Date:  1982-04       Impact factor: 4.030

6.  Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group.

Authors: 
Journal:  JAMA       Date:  1991-12-11       Impact factor: 56.272

7.  Nicotine-produced antinociception in minimally deprived smokers and ex-smokers.

Authors:  J B Fertig; O F Pomerleau; B Sanders
Journal:  Addict Behav       Date:  1986       Impact factor: 3.913

8.  Subjective correlates of cigarette-smoking-induced elevations of peripheral beta-endorphin and cortisol.

Authors:  D G Gilbert; C J Meliska; C L Williams; R A Jensen
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Human plasma beta-endorphin-like peptides: a rapid, high recovery extraction technique and validation of radioimmunoassay.

Authors:  C A Cahill; J D Matthews; H Akil
Journal:  J Clin Endocrinol Metab       Date:  1983-05       Impact factor: 5.958

10.  The effects of cigarette smoking on pain and anxiety.

Authors:  O F Pomerleau; D C Turk; J B Fertig
Journal:  Addict Behav       Date:  1984       Impact factor: 3.913

View more
  4 in total

1.  Attenuated beta endorphin response to acute stress is associated with smoking relapse.

Authors:  Darcy Shaw; Mustafa al'Absi
Journal:  Pharmacol Biochem Behav       Date:  2008-04-03       Impact factor: 3.533

2.  Desensitization of δ-opioid receptors in nucleus accumbens during nicotine withdrawal.

Authors:  Michael J McCarthy; Hailing Zhang; Norton H Neff; Maria Hadjiconstantinou
Journal:  Psychopharmacology (Berl)       Date:  2010-10-13       Impact factor: 4.530

Review 3.  Possible New Symptoms of Tobacco Withdrawal III: Reduced Positive Affect-A Review and Meta-analysis.

Authors:  Elias M Klemperer; John R Hughes; Catherine E Peasley-Miklus; Peter W Callas; Jessica W Cook; Joanna M Streck; Nicolas E Morley
Journal:  Nicotine Tob Res       Date:  2021-01-22       Impact factor: 4.244

4.  Venous plasma nicotine correlates of hormonal effects of tobacco smoking.

Authors:  Yue Xue; Mark Morris; Lisong Ni; Sally K Guthrie; Jon-Kar Zubieta; Kimberly Gonzalez; Daniel S McConnell; Edward F Domino
Journal:  Pharmacol Biochem Behav       Date:  2010-01-25       Impact factor: 3.533

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.